CNSP
Price
$1.15
Change
-$0.08 (-6.56%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
3.99M
PTGX
Price
$45.92
Change
+$0.10 (+0.22%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
2.89B
70 days until earnings call
Interact to see
Advertisement

CNSP vs PTGX

Header iconCNSP vs PTGX Comparison
Open Charts CNSP vs PTGXBanner chart's image
CNS Pharmaceuticals
Price$1.15
Change-$0.08 (-6.56%)
Volume$1.45K
Capitalization3.99M
Protagonist Therapeutics
Price$45.92
Change+$0.10 (+0.22%)
Volume$13.8K
Capitalization2.89B
CNSP vs PTGX Comparison Chart
Loading...
CNSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNSP vs. PTGX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNSP is a Hold and PTGX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (CNSP: $1.22 vs. PTGX: $45.82)
Brand notoriety: CNSP and PTGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNSP: 10% vs. PTGX: 73%
Market capitalization -- CNSP: $3.99M vs. PTGX: $2.89B
CNSP [@Biotechnology] is valued at $3.99M. PTGX’s [@Biotechnology] market capitalization is $2.89B. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNSP’s FA Score shows that 1 FA rating(s) are green whilePTGX’s FA Score has 1 green FA rating(s).

  • CNSP’s FA Score: 1 green, 4 red.
  • PTGX’s FA Score: 1 green, 4 red.
According to our system of comparison, PTGX is a better buy in the long-term than CNSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNSP’s TA Score shows that 5 TA indicator(s) are bullish while PTGX’s TA Score has 4 bullish TA indicator(s).

  • CNSP’s TA Score: 5 bullish, 2 bearish.
  • PTGX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CNSP is a better buy in the short-term than PTGX.

Price Growth

CNSP (@Biotechnology) experienced а +6.09% price change this week, while PTGX (@Biotechnology) price change was +4.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.82%. For the same industry, the average monthly price growth was +7.45%, and the average quarterly price growth was -1.67%.

Reported Earning Dates

CNSP is expected to report earnings on May 15, 2025.

PTGX is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTGX($2.89B) has a higher market cap than CNSP($3.99M). PTGX has higher P/E ratio than CNSP: PTGX (58.74) vs CNSP (0.00). PTGX YTD gains are higher at: 18.705 vs. CNSP (-79.734). PTGX has higher annual earnings (EBITDA): 30.1M vs. CNSP (-17.04M). PTGX has more cash in the bank: 574M vs. CNSP (549K). CNSP has less debt than PTGX: CNSP (31.2K) vs PTGX (11.4M). PTGX has higher revenues than CNSP: PTGX (208M) vs CNSP (0).
CNSPPTGXCNSP / PTGX
Capitalization3.99M2.89B0%
EBITDA-17.04M30.1M-57%
Gain YTD-79.73418.705-426%
P/E Ratio0.0058.740%
Revenue0208M-
Total Cash549K574M0%
Total Debt31.2K11.4M0%
FUNDAMENTALS RATINGS
PTGX: Fundamental Ratings
PTGX
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
42
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CNSPPTGX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 24 days ago
90%
Bearish Trend 9 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
CNSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TCBAX8.80N/A
N/A
Covered Bridge A
EMPTX8.41N/A
N/A
UBS Emerging Markets Equity Opp P2
DLCZX11.05N/A
N/A
Destinations Large Cap Equity Z
ARMIX11.60N/A
N/A
ARGA Emerging Markets Value Instl
RWBEX66.80-0.70
-1.04%
American Funds Capital World Gr&Inc R2E